Back to Search
Start Over
BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure
- Source :
- Endokrynologia Polska. 70:401-408
- Publication Year :
- 2019
- Publisher :
- VM Media SP. zo.o VM Group SK, 2019.
-
Abstract
- Introduction: BRAF(V600E) activating mutation is the most frequent genetic abnormality in the pathogenesis of papillary thyroid carcinoma. We aimed to evaluate the association between BRAF(V600E )mutation and well-established prognostic clinicopathological characteristics as well as iodine exposure. Material and methods: From 2000 to 2012, the data of PTC patients admitted to Dr. Lutfi Kirdar Kartal Education and Research Hospital in Turkey were reviewed retrospectively. Clinicopathological parameters were collected. BRAF(V600E) mutation was analysed by DNA sequencing method in tumour specimens. We hypothesised that BRAF(V600E) mutation prevalence is positively correlated with prolonged iodine exposure and expected to be higher in the second half of the recruitment period due to the increment in time spent from the iodisation process of the table salt in our country. Thus, iodine exposure was categorised as short-term (2000-2006) and long-term (2006-2012). Results: A total of 197 patients were accrued. The study population predominantly consisted of conventional variant. A statistically significant relationship was observed between BRAF(V600E) mutation presence and age (p = 0.03), conventional variant PTC (p = 0.00002), T4 stage (p= 0.002), vascular invasion (p= 0.036), thyroid capsule invasion (p < 0.00001), extrathyroidal tissue invasion (p < 0.00001), and lymph node metastasis (p < 0.00001). When categorised as long-term and short-term, iodine exposure was not statistically significantly related with BRAF(V600E) mutation; however, there were far more PTC cases in the long-term group (86.3% vs. 13.7%). Conclusion: We revealed that BRAF(V600E) mutation is associated with adverse clinicopathological parameters. There appeared to be no relation between long-term iodine exposure and BRAF(V600E). Research Fund of the Tekirdag Namik Kemal University [NKUBAP.01, YL.16.021] This work was supported by a grant of the Research Fund of the Tekirdag Namik Kemal University (Project number: NKUBAP.01.YL.16.021).
- Subjects :
- Adult
Male
Proto-Oncogene Proteins B-raf
medicine.medical_specialty
endocrine system diseases
Endocrinology, Diabetes and Metabolism
DNA Mutational Analysis
chemistry.chemical_element
030209 endocrinology & metabolism
Braf(V600e) Mutation
Iodine
Gene
Gastroenterology
Papillary thyroid cancer
Iodine Radioisotopes
Association
Thyroid carcinoma
Pathogenesis
03 medical and health sciences
0302 clinical medicine
Endocrinology
Recurrence
Internal medicine
Prevalence
medicine
Humans
Neoplasm Invasiveness
papillary thyroid cancer
Thyroid Neoplasms
Stage (cooking)
BRAF V600E
iodine
business.industry
Carcinoma
Middle Aged
medicine.disease
Carcinoma, Papillary
chemistry
Mutation (genetic algorithm)
Population study
Female
Braf V600e Mutation
business
Subjects
Details
- ISSN :
- 22998306 and 0423104X
- Volume :
- 70
- Database :
- OpenAIRE
- Journal :
- Endokrynologia Polska
- Accession number :
- edsair.doi.dedup.....c07216bd4246e80f63e6ba4ce0bbb4d1